Kevin Ohashi
Director/Board Member at MicroVascular Tissues, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Glen G. Gong | M | - |
MicroVascular Tissues, Inc.
 MicroVascular Tissues, Inc. BiotechnologyHealth Technology MicroVascular Tissues, Inc. develops biological vascular tissues for implantation. The company is headquartered in San Diego, CA. | - |
| Greg Lee | M | 77 |
Akeso Biomedical, Inc.
 Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
| Simon Williams | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
| Scott Roth | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
| Anthony Sinskey | M | 83 |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
| Jerome Meier | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
| Robert Goforth | M | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | - |
| Dale L. Peterson | M | - |
MicroVascular Tissues, Inc.
MicroVascular Tissues, Inc. BiotechnologyHealth Technology MicroVascular Tissues, Inc. develops biological vascular tissues for implantation. The company is headquartered in San Diego, CA. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 8 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kevin Ohashi
- Personal Network
